A Phase 1/2 Study of PRO-203 in Healthy Volunteers and Participants With Systemic Sclerosis.

NCT07641634 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers
Systemic Sclerosis (SSc)
Scleroderma, Systemic
Scleroderma

Interventions

DRUG: PRO-203
OTHER: Placebo

Sponsor

Prolium Bioscience, Inc